TNF and rheumatoid arthritis: Biologics such as TNF inhibitors, rituximab, tocilizumab, and synthetic biosimilars have been used to treat difficult-to-treat RA patients or in cases of cDMARD failure or extraarticular severe disease manifestations [18].